Details on scalable financing approach by Q4 earnings
Company: Core Scientific
What the later record shows
Delivered late · happened April 20, 2026
An April 20, 2026 offering document describes a project-level notes financing. It runs through Core Scientific Finance and site subsidiaries, with notes secured by power contracts and CoreWeave license agreements. This came after Q4 earnings, and no passage calls it the 'scalable financing approach'.
“Core Scientific Finance is a Delaware limited liability company and an indirect wholly-owned subsidiary of Core Scientific.”
2026-04-20 · core-scientific 8-K exhibit (d149019dex992.htm) View cached copy (2026-09-09)Live source ↗
“In addition, Core Scientific will pledge the DU Contract to secure the notes as part of the Core Scientific Collateral.”
2026-04-20 · core-scientific 8-K exhibit (d149019dex992.htm) View cached copy (2026-09-09)Live source ↗
Checked October 16, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Core Scientific expects to provide additional details on its scalable financing approach by its Q4 earnings report.
Source (primary)
Investor Conference Call Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-10-16)Live source ↗Archive.org ↗
Quote: “Additional details on scalable financing approach”
How we checked this
Checked on October 17, 2026. The cited source supports every part of this claim.
This item appears under the slide titled 'What to expect by Q4 earnings'.
Confirmed in the source:
- Core Scientific expects to provide additional details on its scalable financing approach by its Q4 earnings
What we did: Read our cached copy of IR page (investors.corescientific.com) (https://d1io3yog0oux5.cloudfront.net/_b76ddaa46c59e7a64138659274ff5f32/corescientific/db/1066/11263/pdf/Core+Scientific+Investor+Update+Presentation+FINAL.pdf) in full (11,378 characters, retrieved October 16, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Investor Conference Call Presentation
Quote: “Additional details on scalable financing approach”
confirms core-scientific 8-K exhibit (d149019dex992.htm)
Quote: “Core Scientific Finance is a Delaware limited liability company and an indirect wholly-owned subsidiary of Core Scientific.”